|
COPYRIGHT 2005 International Medical News Group
BETHESDA, MD. -- Patients infected with extended-spectrum [beta]-lactamase-producing organisms did not have significantly lower mortality if treated with a carbapenem, compared with untreated patients (25.8% vs. 26.1%), reported Jeremias L. Murillo, M.D., at an annual conference on antimicrobial resistance sponsored by the National Foundation for Infectious Diseases.
The retrospective study included 91 patients....
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
